Abstract:BACKGROUND & OBJECTIVE:Cellular keratin, an indicator for cancer cell in circulation gains increasing attention. Although CK19mRNA as a gene marker used to identify micro-metastasis is of relatively high practical value, it lacks specificity and sensitivity in diagnosis of cancer. The aim of this study is to evaluate whether the combined detection of CK19mRNA with other tumor markers, such as carcinoembryanic antigen(CEA), neuron-specific Enolase(NSE), tissue polypeptide antigen(TPA), would improve the diagnosis of lung cancer. METHODS:The expression level of CK19mRNA in peripheral blood mononucleated cells (PBMCS) was determined by RT-PCR, The levels of CEA, NSE, and TPA in serum were determined by enzyme-linked immunosorbent assay (ELISA) and time-resolved fluorometry(TRF) in 91 patients with lung cancer, 33 with benign lung diseases (BLD) and 50 healthy controls. The data was analyzed by t test and chi 2 test. RESULTS:The positive rates of CK19mRNA, CEA, NSE, and TPA in lung cancer group (49.5%, 65.9%, 67.0%, and 83.5%, respectively) were remarkably higher than in BLD group(24.2%, 9.0%, 15.2%, and 9.0%, respectively) and in healthy control group (10.0%, 4.0%, 8.0%, and 6.0%, respectively) (P < 0.01). The positive rate of CK19mRNA was not statistically different in various histological subtypes (P > 0.05). Although the positive rate of CK19mRNA appeared to be associated with the clinical stage (stage I + II: 44.4%, stage III: 48.4%, stag IV: 54.2%), there was no statistical significance among the three groups (P > 0.05). The serum level (microgram/L)/positive rate of CEA(3.5/27.8%, 5.1/35.5%, and 8.5/58.3%, respectively), NSE (12.5/33.3%, 15.3/41.9%, and 24.7/58.3%, respectively), and TPA (1.1/44.4%, 1.8/58.1%, and 3.6/66.7%, respectively) in stage I + II, III, and IV appeared to be associated with the clinical stages of lung cancer, but no statistical significance among the three groups (P > 0.05). Combined detection of three or four tumor markers yielded significant higher effective accuracy in diagnosis of lung cancer than that of any of two tumor markers or single tumor marker (P < 0.05). In addition, the results showed that TPA, CEA, and NSE were relatively specific for squamous cell carcinoma (76.7%), adenocarcinomas (83.3%), and small-cell lung cancer (79.2%), respectively. CONCLUSION:The combined measurement of CK19mRNA with CEA, NSE, and TPA can increase diagnosis rate of lung cancer, can also provide potent diagnosis basis for treatment.

Significance of Combined Detection of LunX Mrna and Tumor Markers in Diagnosis of Lung Carcinoma.

[Significance of Combined Determination of CK19mRNA, Carcinoembryanic Antigen, Neuron-Specific Enolase, and Tissue Polypeptide Antigen in Peripheral Blood of Patients with Lung Cancer].

Diagnostic Value of Combined Determination of Serum Tumor Markers(CEA,CA125,NSE,CYFRA21-1) Levels in Patients with Lung Cancer

Clinical significance of combined detection tumor markers in patients with lung cancer

Application of combined detection of tumor markers, SCC-Ag, cyf21-1, CEA, ProGRP, and NSE in the diagnosis of lung cancer

Clinical study of combined determination of CYFRA21-1, CEA, NSEin the patients with lung c ancer

Combination Detection of Three Gene Markers Expressed in Circulating Cancer Cells of Non-Small Cell Lung Cancer

Diagnostic Utility of LunX Mrna in Peripheral Blood and Pleural Fluid in Patients with Primary Non-Small Cell Lung Cancer

Biomarkers in the Lung Cancer Diagnosis: a Clinical Perspective.

Lack of Efficacy of Combined Carbohydrate Antigen Markers for Lung Cancer Diagnosis

[Combined Detection of CEA Mrna and CK 19 Mrna in Peripheral Blood Cells of Patients with Lung Cancer].

Clinical significance of CEA and CK20 expression in exfoliated cells by fiberoptic bronchoscopy brushing

Application Value of CYFRA21-1 Combined with NSE, CEA, and SCC-Ag in Lung Cancer.

Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer

Clinical Significance of Lunx mRNA Expression in Peripheral Blood of Lung Cancer Patients

Combining multiple serum biomarkers in tumor diagnosis: A clinical assessment.

Clinical Significance of Expressions of LunX and CK19 Mrna in Peripheral Blood in Lung Cancer

Comprehensive analysis of marker gene detection and computed tomography for the diagnosis of human lung cancer

Study on the correlationship between CK19mRNA and CyFRA21-1 in peripheral blood of lung cancer patients

The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer

Evaluation of clinical value of combined tumor markers detection in diagnosis of lung cancer